Chromadex Corp (CDXC) Down 2.01% in Premarket Trading

Chromadex Corp (CDXC) is lower by Tuesday morning, with the stock decreasing -2.01% in pre-market trading to 2.93. CDXC's short-term technical score of 97 indicates that the stock has traded more bullishly over the last month than 97% of stocks on the market. In the Biotechnology industry, which ranks 98 out of 146 industries, Chromadex Corp ranks higher than 98% of stocks. Chromadex Corp has risen 84.57% over the past month, closing at $1.59 on February 20. During this period of time, the stock fell as low as $1.52 and as high as $2.40. CDXC has an average analyst recommendation of Strong Buy. The company has an average price target of $5.55.

CDXC has an Overall Score of 91. Find out what this means to you and get the rest of the rankings on CDXC!

See Full CDXC Report

Chromadex Corp has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Biotechnology industry which is number 74 by this metric, CDXC ranks better than 74% of stocks.

Important Dates for Investors in CDXC:

-Chromadex Corp is set to release earnings on 2024-05-08. Over the last 12 months, the company has reported EPS of $0.12. -We do not have a set dividend date for Chromadex Corp at this time. Click Here To Get The Full Report on Chromadex Corp (CDXC)